Healthy adult women scheduled to complete skin laser treatment
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Women who can obtain written consent (2) Women who are between 20 and 60 years old when obtaining consent (3) Women with laser treatment target sites on both the left and right sides of the face (4) Women who can go to the hospital according to the study schedule
Exclusion criteria
Exclusion criteria: (1) Persons with histories of allergies to cosmetic (2) Person receiving any hormone replacement therapies (3) Pregnant and breastfeeding women (4) Persons who have experience in cosmetic medicine that affects the evaluation site, or who are scheduled to receive it during the study period (5) Persons who have undergone special skin care (e.g., beauty salon, esthetic salon) for the evaluation site within the past 4 weeks or who are scheduled to receive it during the study period (6) Persons with inflammation or skin disease that affects evaluation (7) Persons who are judged to be inappropriate for participation in this study by the principal investigator or other investigators (hereinafter referred to as the investigators)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of skin moisture (test site): Evaluation is made before application of the test product or placebo, 1 week, 2 weeks, 4 weeks and 6 weeks after the start of application of the test product or placebo. | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin moisture measurement (1 cheek site of each split face) Evaluation of skin findings by doctors Analysis of changes in skin conditions using digital camera images Participant questionnaire Incidence of adverse events Skin moisture measurement and analysis of digital camera images are evaluated before application of the test product or placebo, 1 week, 2 weeks, 4 weeks, and 6 weeks after application of the test product or placebo. The skin findings are evaluated 1 week, 2 weeks, 4 weeks and 6 weeks after the start of application of the test product or placebo. The questionnaire for the participants will be evaluated 2 weeks, 4 weeks and 6 weeks after the start of application of the test product or placebo. In addition, safety will be checked throughout the period. | — |
Countries
Japan
Contacts
Kitasato University, school of medicine Department of Plastic & Aesthetic Surgery